BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 18719732)

  • 1. [Preliminary evaluation of maggot (Diptera: Calliphoridae) therapy as a potential treatment for leishmaniasis ulcers].
    Arrivillaga J; Rodríguez J; Oviedo M
    Biomedica; 2008 Jun; 28(2):305-10. PubMed ID: 18719732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Maggot therapy in wound management].
    Falch BM; de Weerd L; Sundsfjord A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1864-7. PubMed ID: 19844278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.
    Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ
    BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biosurgical wound debridement: experimental investigation of efficiency and practicability.
    Blake FA; Abromeit N; Bubenheim M; Li L; Schmelzle R
    Wound Repair Regen; 2007; 15(5):756-61. PubMed ID: 17971022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Maggots of Lucilia sericata in treatment of intractable wounds].
    Orkiszewski M
    Wiad Lek; 2007; 60(7-8):381-5. PubMed ID: 18175560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Maggot therapy with Lucilia sericata for debridement of chronic wounds].
    Cartier E; Combemale P
    Ann Dermatol Venereol; 2008 Oct; 135(10):685-8. PubMed ID: 18929922
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of Lucilia sericata- and Sarconesiopsis magellanica-derived larval therapy on Leishmania panamensis.
    Cruz-Saavedra L; Díaz-Roa A; Gaona MA; Cruz ML; Ayala M; Cortés-Vecino JA; Patarroyo MA; Bello FJ
    Acta Trop; 2016 Dec; 164():280-289. PubMed ID: 27686957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maggot-therapy in veterinary medicine.
    Jones G; Wall R
    Res Vet Sci; 2008 Oct; 85(2):394-8. PubMed ID: 18237754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity of Lucilia sericata maggot secretions.
    Daeschlein G; Mumcuoglu KY; Assadian O; Hoffmeister B; Kramer A
    Skin Pharmacol Physiol; 2007; 20(2):112-5. PubMed ID: 17167275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae.
    Nuesch R; Rahm G; Rudin W; Steffen I; Frei R; Rufli T; Zimmerli W
    Infection; 2002 Oct; 30(5):306-9. PubMed ID: 12382092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti Leishmania activity of Lucilia sericata and Calliphora vicina maggots in laboratory models.
    Sanei-Dehkordi A; Khamesipour A; Akbarzadeh K; Akhavan AA; Mir Amin Mohammadi A; Mohammadi Y; Rassi Y; Oshaghi MA; Alebrahim Z; Eskandari SE; Rafinejad J
    Exp Parasitol; 2016 Nov; 170():59-65. PubMed ID: 27567983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the use of maggots in wound therapy.
    Gupta A
    Ann Plast Surg; 2008 Feb; 60(2):224-7. PubMed ID: 18216520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating wounds in small animals with maggot debridement therapy: a survey of practitioners.
    Sherman RA; Stevens H; Ng D; Iversen E
    Vet J; 2007 Jan; 173(1):138-43. PubMed ID: 16386439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid derivatives from Lucilia sericata excretions/secretions may contribute to the beneficial effects of maggot therapy via increased angiogenesis.
    Bexfield A; Bond AE; Morgan C; Wagstaff J; Newton RP; Ratcliffe NA; Dudley E; Nigam Y
    Br J Dermatol; 2010 Mar; 162(3):554-62. PubMed ID: 19799603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
    Gilead L; Mumcuoglu KY; Ingber A
    J Wound Care; 2012 Feb; 21(2):78, 80, 82-85. PubMed ID: 22584527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presurgical maggot debridement of soft tissue wounds is associated with decreased rates of postoperative infection.
    Sherman RA; Shimoda KJ
    Clin Infect Dis; 2004 Oct; 39(7):1067-70. PubMed ID: 15472863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maggot therapy for gangrene and osteomyelitis].
    Mumcuoglu KY; Lipo M; Ioffe-Uspensky I; Miller J; Galun R
    Harefuah; 1997 Mar; 132(5):323-5, 382. PubMed ID: 9153871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata.
    Telford G; Brown AP; Rich A; English JS; Pritchard DI
    Med Vet Entomol; 2012 Sep; 26(3):291-9. PubMed ID: 22620282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearing larvae of Lucilia sericata for chronic ulcer treatment--an improved method.
    Wolff H; Hansson C
    Acta Derm Venereol; 2005; 85(2):126-31. PubMed ID: 15823905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does maggot therapy promote wound healing? The clinical and cellular evidence.
    Nigam Y; Morgan C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):776-82. PubMed ID: 26691053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.